CON vs VEON
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CON · Concentra Group$42.22 ▲ 0.17%
VEON · VEON Ltd$77.57 ▲ 2.96%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CON +121.4%
- VEON +55.1%
Head to head
| Metric | CON | VEON |
|---|---|---|
| Price | $42.22 | $77.57 |
| Change today | ▲ 0.17% | ▲ 2.96% |
| Market cap | $5.34B | $5.34B |
| Return, 3 months | +24.0% | +38.8% |
| Return, year to date | +116.0% | +47.6% |
| Return, 1 year | +120.5% | +78.0% |
| P/E (TTM) | 25.0 | 77.6 |
| P/B | 10.5 | 3.5 |
| P/E percentile vs own 5y | 100th | 99th |
| Dividend yield | 0.59% | – |
| Revenue growth (YoY, latest qtr) | +10.0% | +16.9% |
| Net profit growth (YoY) | +45.7% | -77.0% |
| Gross margin | 29.3% | 87.1% |
| Operating margin | 16.4% | 24.0% |
| Net margin | 8.6% | 1.2% |
| Return on equity | 48.1% | 4.2% |
| Analyst target vs. price | -0.5% | +24.0% |
| Analyst buy share | 92% | 100% |
| RSI (14) | 66 | 47 |
| 30-day volatility | 34.3% | 49.2% |
| Max drawdown, 1 year | -13.3% | -21.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CON is the largest of the group by market value.
- CON has returned the most over the past year.
- CON carries the lowest trailing P/E.
- VEON is growing revenue fastest.
- CON keeps the most profit per dollar of sales.
- CON has been the calmest stock over the last 30 days.